Coherus Oncology Inc (CHRS)

EV/EBITDA

-0.76×

TTM · Retrieved:

CHRS logo

CHRS EV/EBITDA

Current (TTM)-0.76×
CHRS Quarterly EV/EBITDA (-5.37× → -5.69×)
High-resolution chart · PNG

CHRS ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc EV/EBITDA — Quarterly
Period endingEV/EBITDA
-5.6868×
-5.0091×
-2.8328×
-3.1038×
2.1886×
-6.3575×
-6.8415×
-76.0426×
-50.6191×
-7.7587×
-11.0227×
-26.4612×
-24.2945×
-15.4527×
-21.3541×
-12.0471×
-16.7485×
-12.7624×
-31.6922×
-41.481×
-48.6851×
-7.3425×
65.4969×
41.6465×
21.94×
27.5146×
27.24×
26.8502×
58.0791×
-66.7296×
-10.8584×
-19.7948×
-21.4977×
-16.7015×
-10.6666×
-12.3117×
-14.634×
-14.0528×
-16.8014×
12.6916×
-9.0236×
-11.7824×
-14.3632×
-8.6827×
-15.0536×
-22.3001×
-6.9395×
-8.6847×
-5.0778×
-7.9964×
-17.2316×
0×
0×
-5.37×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.